Goetz, Eva M.
Broad Institute · Brigham and Women's Hospital · Harvard University · Harvard–MIT Division of Health Sciences and Technology · Dana-Farber Cancer Institute · Massachusetts Institute of Technology
2 papers on CoChat
Most cited papers
- Verified
MAP Kinase Pathway Alterations in BRAF -Mutant Melanoma Patients with Acquired Resistance to Combined RAF/MEK Inhibition
Wagle, N., Van Allen, E. M., Treacy, D. J., Frederick, D. T., Cooper, Z. A., Taylor-Weiner, A., Rosenberg, M., Goetz, E. M., Sullivan, R. J., Farlow, D. N., et al. (2014) · Cancer Discovery
Melanoma and MAPK PathwaysLung Cancer Treatments and Mutations
Cited by 478
- Verified
Reactivation of ERK signaling causes resistance to EGFR kinase inhibitors.
Ercan, D., Xu, C., Yanagita, M., Monast, C. S., Pratilas, C. A., Montero, J., Butaney, M., Shimamura, T., Sholl, L., Ivanova, E. V., et al. (2012) · Cancer Discovery
Lung Cancer Treatments and MutationsHER2/EGFR in Cancer Research
Cited by 294
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free